ATE181104T1 - Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung - Google Patents

Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung

Info

Publication number
ATE181104T1
ATE181104T1 AT91106110T AT91106110T ATE181104T1 AT E181104 T1 ATE181104 T1 AT E181104T1 AT 91106110 T AT91106110 T AT 91106110T AT 91106110 T AT91106110 T AT 91106110T AT E181104 T1 ATE181104 T1 AT E181104T1
Authority
AT
Austria
Prior art keywords
genes
plasmid
isolated
keterological
pctd
Prior art date
Application number
AT91106110T
Other languages
English (en)
Inventor
Giulio Ratti
Maurizio Comanducci
Mario F Tecce
Marzia M Giuliani
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Application granted granted Critical
Publication of ATE181104T1 publication Critical patent/ATE181104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91106110T 1991-02-07 1991-04-17 Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung ATE181104T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Publications (1)

Publication Number Publication Date
ATE181104T1 true ATE181104T1 (de) 1999-06-15

Family

ID=11358472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91106110T ATE181104T1 (de) 1991-02-07 1991-04-17 Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung

Country Status (8)

Country Link
US (2) US6110705A (de)
EP (1) EP0499681B1 (de)
AT (1) ATE181104T1 (de)
DE (1) DE69131319T2 (de)
DK (1) DK0499681T3 (de)
ES (1) ES2136062T3 (de)
GR (1) GR3030447T3 (de)
IT (1) IT1244706B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5814490A (en) * 1996-06-11 1998-09-29 Becton, Dickinson And Company Amplification and detection of chlamydia trachomatis nucleic acids
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
DE60228758D1 (de) 2001-12-12 2008-10-16 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia tracheomatis
US8440208B2 (en) 2007-05-01 2013-05-14 Board Of Regents, The University Of Texas System Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US9068007B2 (en) 2008-10-09 2015-06-30 Board Of Regents, The University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143414T1 (de) * 1985-01-14 1996-10-15 Chiron Corp Hauptprotein der aussenmembran von chlamydia
GB8709746D0 (en) * 1987-04-24 1987-05-28 Wenman W M Chlamydia vaccine
IT1224253B (it) * 1988-04-08 1990-09-26 Sclavo Spa Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico

Also Published As

Publication number Publication date
US6110705A (en) 2000-08-29
EP0499681B1 (de) 1999-06-09
IT1244706B (it) 1994-08-08
ITMI910314A0 (it) 1991-02-07
DK0499681T3 (da) 1999-11-15
ITMI910314A1 (it) 1992-08-07
ES2136062T3 (es) 1999-11-16
EP0499681A1 (de) 1992-08-26
DE69131319D1 (de) 1999-07-15
DE69131319T2 (de) 1999-12-16
US6096519A (en) 2000-08-01
GR3030447T3 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
DE69019609D1 (de) Proteine und deren Herstellung.
KR970707281A (ko) 풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine)
IE811463L (en) Interferons
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
SG48353A1 (en) Helicobacter pylori proteins useful for vaccines and diagnostics
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DE69735207T2 (de) Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
ATE181104T1 (de) Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
HU9401511D0 (en) Vaccine against streptococcus suls infection
DE69223502T2 (de) Gen für die glykoprotease aus pasteurella haemolytica
DK0425082T3 (da) Vacciner
DE69019359D1 (de) Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
DE69330778T2 (de) Vogel-mycoplasmaantigen, sein gen, das gen enthaltender rekombinanter vektor, und damit hergestellter impfstoff
US6783764B1 (en) Actinobacillus pleuropneumoniae subunit vaccine
GB9727512D0 (en) Fuzzy genes and their application in molecular adjuvants
DE3878553T2 (de) Klonierung und sequenzierung des gens, das fuer eine neue pilinische untereinheit von bordetella pertussis kodiert.
EP1518558B1 (de) Impfstoffe gegen Actinobacillus pleuropneumoniae Infektion, die hochreines Toxin enthalten
ATE435915T1 (de) Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
IT1202612B (it) Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
DE69128095T2 (de) Azelluläre impfstoffe
Hodges et al. Immunodominant region of EDP 208 pili: Antigen-antibody interaction.
AU1541595A (en) Expression of heterologous proteins in attenuated bacteria using the htra-promoters
IE84132B1 (en) OspA Lipoproteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time